Children with Epilepsy in Kazakhstan May Lose Access to Crucial Medication in 2027

Parents of children with epilepsy in Kazakhstan fear losing access to the medication 'Sulthiam' (Ospolot) by January 1, 2027, as it will be removed from the list of free drugs. The Ministry of Health cites insufficient evidence of the drug's effectiveness and its lack of registration with the FDA and EMA. Alternative therapies are being sought.

Read the full article at Kursiv →

Headline and summary written by daryo. The full report belongs to Kursiv.